Global Plasmapheresis Device Market Size By Type (Source Plasma Collection, Therapeutic Plasmapheresis), By Application (Biopharmaceutical Companies, Hospitals And Clinics), By Region, And Segment For...

The Global Plasmapheresis Device Market was valued at USD 1.35 billion in 2023 and is projected to reach USD 2.42 billion by 2031, expanding at a CAGR of 7.6% during the forecast period of 2023 to 2031. This growth is primarily driven by the increasing prevalence of autoimmune diseases, rising demand for blood component separation, and technological advancements in apheresis systems. Plasmapheresis devices are instrumental in therapeutic procedures for conditions such as Guillain-Barré syndrome, myasthenia gravis, and multiple sclerosis, enabling the removal of pathogenic substances from the plasma. Additionally, the rise in plasma collection for fractionation and biopharmaceutical production further fuels the demand.

Drivers:

1. Rising Incidence of Autoimmune and Neurological Disorders:

Autoimmune and neurological diseases are witnessing a global rise. Plasmapheresis is a critical component in treating conditions like lupus and CIDP, enhancing the relevance of these devices in therapeutic settings.

2. Increasing Demand for Source Plasma in Biopharma Manufacturing:

With a surge in demand for plasma-derived therapies, pharmaceutical companies are heavily reliant on plasmapheresis collection systems, thus propelling market expansion.

3. Technological Advancements in Apheresis Equipment:

Next-generation plasmapheresis devices are being developed with automation, portability, and patient-friendly interfaces. These innovations contribute to better clinical outcomes and operational efficiency in blood centers and hospitals.

Restraints:

1. High Equipment and Maintenance Costs:

Despite their therapeutic benefits, plasmapheresis devices are capital-intensive and come with recurring maintenance and consumables costs, potentially limiting their adoption in low-resource settings.

2. Procedural Risks and Lack of Skilled Operators:

Plasmapheresis requires well-trained professionals, and associated risks such as hypotension or citrate reactions may deter broader adoption, especially in underdeveloped healthcare systems.

Opportunity:

1. Emerging Market Expansion and Contract Plasma Collection Centers:

Developing countries are investing in healthcare infrastructure and plasma collection networks. The emergence of contract plasma centers is anticipated to generate new growth avenues for device manufacturers.

2. Integration of AI and Data Analytics in Apheresis Systems:

Innovations such as real-time monitoring, predictive maintenance, and personalized treatment protocols through AI-integrated plasmapheresis platforms offer future growth potential.

Market by System Type Insights:

In 2023, the Automated Plasmapheresis Devices segment held the largest market share due to their efficiency, minimal human intervention, and higher plasma yield. These systems are preferred in high-throughput settings like blood banks and clinical research organizations. Manual systems are still utilized in smaller healthcare facilities but are expected to grow at a slower pace.

Market by End-use Insights:

Blood Collection Centers represented the dominant end-use segment in 2023, owing to rising plasma donation drives and increasing support from governments and NGOs. Hospitals and Clinics follow closely, particularly where plasmapheresis is used for therapeutic purposes. Research & Academic Institutions also contribute to the market, especially in biologics development and clinical studies.

Market by Regional Insights:

North America led the global plasmapheresis device market in 2023, driven by an established healthcare system, high prevalence of autoimmune diseases, and robust regulatory support for plasma donation. Asia-Pacific is poised to be the fastest-growing region due to increasing healthcare investments, growing patient awareness, and expanding plasma fractionation infrastructure in countries like China and India.

Competitive Scenario:

Key players in the Global Plasmapheresis Device Market include:

Terumo BCT, Inc.

Fresenius Kabi

Haemonetics Corporation

B. Braun Melsungen AG

Asahi Kasei Medical Co., Ltd.

Kawasumi Laboratories Inc.

Cerus Corporation

Baxter International Inc.

Medica S.p.A.

Shangdong Zhongbaokang Medical Implements Co., Ltd.

These companies focus on strategic partnerships, innovation in automation, and global expansion of manufacturing capabilities. For instance, in 2024, Haemonetics launched an AI-integrated apheresis system designed to enhance procedural safety and plasma yield efficiency.

Scope of Work – Global Plasmapheresis Device Market

Report Metric Details

Market Size (2023) USD 1.35 Billion

Projected Market Size (2031) USD 2.42 Billion

CAGR (2023–2031) 7.6%

Market Segments By System Type (Automated, Manual); By End-use (Hospitals, Blood Centers, Research)

Growth Drivers Rising autoimmune diseases, demand for plasma collection, tech advancements

Opportunities Emerging markets, AI integration in devices

Key Market Developments:

April 2024: Fresenius Kabi introduced a next-gen plasmapheresis platform with real-time plasma composition analysis for improved donor safety.

January 2024: Terumo BCT partnered with Red Cross Asia to deploy automated a